Aug 2026· Molecular Cancer· Vol 25· 0 citations· 173 references
Medicine
TL;DR
This review proposes the concept of spatially organized RCD-immune coupling as a hypothesis-generating framework and argues that RCD modalities are not uniformly distributed across tumors, but are influenced by regional microenvironmental constraints, including metabolic zonation, hypoxia, and mechanical stress.
Abstract
The therapeutic efficacy of immune checkpoint blockade is frequently compromised by the profound spatial heterogeneity of solid tumors, where distinct ecological niches are associated with different patterns of immune engagement. Spatial omics has substantially refined our understanding of tumor immune topographies. These range from immune-excluded hypoxic and necrotic cores to immune-infiltrated margins enriched with tertiary lymphoid structures (TLS). However, the mechanistic contribution of regulated cell death (RCD) to these spatial domains remains largely unexplored. In this review, we propose the concept of spatially organized RCD-immune coupling as a hypothesis-generating framework. We argue that RCD modalities are not uniformly distributed across tumors, but are influenced by regional microenvironmental constraints, including metabolic zonation, hypoxia, and mechanical stress. Synthesizing emerging evidence, we discuss how apoptosis, necroptosis, pyroptosis, ferroptosis, and PANoptosis may be enriched within distinct tumor niches. We further examine how region-specific release of damage-associated molecular patterns (DAMPs), cytokines, and lipid mediators may be associated with local immune activation, exhaustion, or exclusion. Importantly, we distinguish spatial association from functional causality and emphasize the need for phenotypic validation and perturbation-based studies. This framework positions RCD as a spatially organized component of tumor immune ecology and a basis for future biomarker and therapeutic studies.
Tertiary lymphoid structures (TLSs) have emerged as clinically relevant immune niches associated with improved survival and enhanced response to immune checkpoint inhibitors across multiple solid tumors. However, translational evaluation remains dominated by density-based scoring, which inadequately captures the fu...
Xu-Chen Wang, Lin Lin· Frontiers in Immunology· 0 citations
This work reframes macrophage efferocytosis as a spatially and temporally constrained determinant of immune contexture with important implications for precision immunotherapy, combination design, and trial optimization.
Shan-Yi Li, Ji-Lei Li, Zhen-Yu Zhang et al.· Cancer Medicine· 0 citations
This work proposes that metabolite-driven remodeling of the tumor microenvironment is a major cause of intratumoral TLS failure and outlines biomarker-guided strategies to restore TLS competence, including inhibition of tumor-derived tryptophan metabolism to promote TLS maturation and enhance anti-PD-1 efficacy.
Yi-Feng Wang, Yan Li, Shu-Juan Wei et al.· Frontiers in Immunology· 0 citations
This chapter provides an integrated framework for understanding TAM biology across multiple regulatory dimensions, including ontogeny, plasticity, metabolism, epigenetic control, and spatial niche organization, and synthesizes current and emerging therapeutic strategies targeting TAM recruitment, survival, reprogrammin...
Atif Elnaggar, Abdelrahman Elnaggar· Advances in Cancer Research· 0 citations
The mechanisms through which malignant, myeloid, lymphoid, endothelial, and stromal populations interact across spatial niches are discussed, and how these maps can inform biomarker discovery, patient stratification, and rational combination therapy are examined.